Data / Medical devices / Spain / Biokit S.A.
Biokit S.A.: FDA-registered device maker in LLISSA D AMUNT Barcelona, Spain, 38 510(k) clearances and 1 PMA approval
Biokit S.A. is registered with the FDA (registration 9610746) in LLISSA D AMUNT Barcelona, Spain. It lists 40 device types. The FDA files 38 510(k) clearances and 1 PMA approval under its listings, the newest dated February 12, 2025. 1 recall event names it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 9610746
- FEI number
- 3002806557
- Address
- Av. Can Montcau 7, LLISSA D AMUNT Barcelona, Spain, 08186
- Owner or operator
- BIOKIT S.A. (8030752)
- Roles
- Contract manufacturer, Exporter to the US, Manufacturer, Repackager or relabeler, Specification developer
- First device listed
- April 10, 1980
- Registered through
- 2027
- Brand names listed
- ADVIA Centaur EBV-EBNA IgG, ADVIA Centaur EBV-EBNA IgG Quality Control, ADVIA Centaur EBV-VCA IgM, ADVIA Centaur EBV-VCA IgM Quality Control, ADVIA Centaur Herpes-1 IgG (HSV1), ADVIA Centaur Herpes-1 IgG (HSV1) Quality Control, ADVIA Centaur Herpes-2 IgG (HSV2), ADVIA Centaur Herpes-2 IgG (HSV2) Quality Control and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| February 12, 2025 | K243575 | ARCHITECT HSV-2 IgG, ARCHITECT HSV-2 IgG Calibrator, ARCHITECT HSV-2 IgG Controls | MYF | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| January 28, 2025 | K243374 | HemosIL CL HIT-IgG(PF4-H) | LCO | Substantially Equivalent | Instrumentation Laboratory (IL) Co. | accessdata.fda.gov |
| September 29, 2023 | K221359 | ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM | JPA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| September 20, 2023 | K213987 | ARCHITECT HSV-1 IgG, ARCHITECT HSV-1 IgG Calibrator, ARCHITECT HSV-1 IgG Controls | MXJ | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| February 21, 2023 | K214068 | Quantia IgE | DGC | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| December 9, 2022 | K223402 | HemosIL von Willebrand Factor Antigen | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 23, 2018 | K181334 | ADVIA Centaur Herpes-2 IgG | MYF | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| August 23, 2018 | K181333 | ADVIA Centaur Herpes-1 IgG | MXJ | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| November 22, 2017 | K172903 | HemosIL D-Dimer HS 500 | DAP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 3, 2017 | K170314 | ACL AcuStar | JPA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| October 27, 2016 | K160885 | HemosIL D-Dimer HS | DAP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| July 8, 2016 | K153137 | HemosIL HIT-Ab(PF4-H), HemosIL HIT-Ab(PF4-H) Controls | LCO | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 15, 2014 | K133582 | HEMOSIL D-DIMER HS 500 CONTROL | GGN | Substantially Equivalent | Instrumentation Laboratory | accessdata.fda.gov |
| March 13, 2014 | K133005 | HEMOSIL VON WILLEBRAND ACTIVITY ASSAY | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 19, 2013 | K132400 | LP(A) CALIBRATORS, AND LP(A) CONTROLS | JIT | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| August 29, 2013 | K123947 | ARCHITECT IVANCOMYCIN | LEH | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| February 5, 2010 | K090264 | HEMOSIL D-DIMER HS 500, CONTROLS | DAP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 13, 2009 | K083518 | ACL ACUSTAR, HEMOSIL ACUSTAR D-DIMER, HEMOSIL ACUSTAR D-DIMER CONTROLS | JPA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 22, 2008 | K082953 | ARCHITECT IDIGOXIN AND ARCHITECT IDIGOXIN CALIBRATORS, MODELS 1P32-25 AND IP32-01 | KXT | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| September 3, 2008 | K082141 | ARCHITECT C-PEPTIDE CALIBRATORS, AND ARCHITECT C-PEPTIDE CONTROLS, MODELS 3L53-01, 3L53-10 | JIT | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| July 31, 2008 | K073042 | HEMOSIL D-DIMER | DAP | Substantially Equivalent | Instrumentation Laboratory | accessdata.fda.gov |
| September 17, 2007 | K070927 | HEMOSIL D-DIMER HS | DAP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| June 19, 2007 | K063232 | ARCHITECT INTACT PTH REAGENTS, CALIBRATORS (A-F) AND CONTROLS (LOW, MEDIUM, HIGH), MODELS 8K25-20, 8K25-25, 8K25-01 | CEW | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| June 8, 2007 | K070810 | ARCHITECT I THEOPHYLLINE REAGENTS AND CALIBRATORS (A-F) | LGS | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| January 23, 2007 | K060818 | ARCHITECT SHBG REAGENT KIT, ARCHITECT SHBG CALIBRATOR KIT, AND ARCHITECT SHBG CONTROL KIT WITH MODELS, 8K26-25, 8K26-01 | CDZ | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| September 22, 2006 | K061598 | HEMOSIL HOMOCYSTEINE AND CONTROLS | LPS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 26, 2006 | K060027 | ARCHITECT DHEA-S CALIBRATORS (A-F) AND CONTROLS (LOW, MEDIUM AND HIGH) | JJX | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| August 16, 2005 | K050613 | QUANTIA BETA-2 MICROGLOBULIN | JZG | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| August 16, 2005 | K050493 | QUANTIA IGE | DGC | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| May 13, 2005 | K050596 | QUANTIA A1-AT | DEM | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| April 26, 2005 | K050487 | QUANTIA LA(A) | DFC | Substantially Equivalent | Biokit, S.A. | accessdata.fda.gov |
| May 10, 2004 | K040879 | QUANTEX FERRITIN | DBF | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| April 13, 2001 | K010379 | IL TEST FREE PROTEIN S | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| February 2, 1999 | K984437 | QUANTEX ASO-CRP-RP CONTROL II | JJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 27, 1997 | K971777 | QUANTEX ASO-CRP-RF CONTROL | JJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| April 5, 1991 | K910539 | RHEUMAJET RF | DHR | Substantially Equivalent | Biokit USA, Inc. | accessdata.fda.gov |
| October 24, 1989 | K894486 | QUANTEX ASO PLUS (LATEX,BUFFER STANDARD,CONTROL) | GTQ | Substantially Equivalent | Biokit USA, Inc. | accessdata.fda.gov |
| December 14, 1987 | K874678 | I.M.N. LATEX | KTN | Substantially Equivalent | Biokit USA, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| July 14, 2021 | P200017 | ADVIA Centaur Anti-HBe2 (aHBe2) assay | SEI | 4 | October 17, 2025 | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| September 28, 2022 | 91384 | Class II | Ongoing | biokitHSV-2 Rapid Test, REF: 300028001 | HSV-2 rapid test may report false positive results. | accessdata.fda.gov |
Compare with other makers
- All makers of Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1
- All makers of Alpha-1-Acid-Glycoprotein, Antigen, Antiserum, Control
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of Ige, Antigen, Antiserum, Control
- All makers of Controls For Blood-Gases, (Assayed And Unassayed)
- All makers of System, Multipurpose For In Vitro Coagulation Studies
Updated October 17, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.